Constitutional reform initiative regarding pharmaceutical sovereignty and safety. By: Blanca Date: May 02, 2025 Comment: 0 Category: Newsletters - Life Science Read More
Iniciativa de reforma constitucional en materia de soberanía y seguridad farmacéutica. By: Blanca Date: May 02, 2025 Comment: 0 Category: Newsletters - Life Science Read More
Unprecedented nullification of the biannual public tender formedicine procurement. By: Blanca Date: Apr 25, 2025 Comment: 0 Category: Newsletters - IP Litigation, Alternative Dispute Resolution Read More
Inédita nulidad de la licitación bianual para adquisición de medicamentos. By: Blanca Date: Apr 25, 2025 Comment: 0 Category: Newsletters - IP Litigation, Alternative Dispute Resolution Read More
New guidelines establishing the requirements and procedures that must be observed to obtain permission to advertise prepackaged food and non-alcoholic beverages. By: Blanca Date: Mar 31, 2025 Comment: 0 Category: Newsletters - Life Science Read More
Nuevos lineamientos que establecen los requisitos y procedimientos que deben observarse para obtener un permiso de publicidad de alimentos preenvasados y bebidas no alcohólicas. By: Blanca Date: Mar 31, 2025 Comment: 0 Category: Newsletters - Life Science Read More
Extinction of the National Institute for Transparency, Access to Information, and Personal Data Protection. By: Blanca Date: Mar 25, 2025 Comment: 0 Category: Newsletters - IT & Data Privacy Law Read More
Extinción del Instituto Nacional de Transparencia, Acceso a la Información y Protección de Datos Personales. By: Blanca Date: Mar 25, 2025 Comment: 0 Category: Newsletters - IT & Data Privacy Law Read More
New Decree for Patent Linkage by the Mexican Government. By: Blanca Date: Mar 24, 2025 Comment: 1 Category: Newsletters - IP Litigation, Alternative Dispute Resolution Read More
Nuevo Decreto para la Vinculación de Patentes por parte del Gobierno Mexicano. By: Blanca Date: Mar 24, 2025 Comment: 0 Category: Newsletters - IP Litigation, Alternative Dispute Resolution Read More
